Filing Details

Accession Number:
0000950138-20-000310
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-04 16:15:18
Reporting Period:
2020-08-03
Accepted Time:
2020-08-04 16:15:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1739104 Elanco Animal Health Inc ELAN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1682584 S. Todd Young C/O Elanco Animal Health Incorporated
2500 Innovation Way
Greenfield IN 46140
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-03 2,000 $23.85 2,000 No 4 P Indirect by J. G. Young IRA
Common Stock Acquisiton 2020-08-03 5,000 $23.94 5,000 No 4 P Indirect by IRA
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect by J. G. Young IRA
No 4 P Indirect by IRA
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Tangible Equity Units Acquisiton 2020-08-03 1,000 $40.55 1,562 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,000 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 41,513 Direct
Footnotes
  1. Each 5.00% Tangible Equity Unit (TEU) includes a prepaid stock purchase contract that will automatically settle on February 1, 2023 (unless settled early at the holder's discretion) for between 1.3021 and 1.5625 shares of Elanco's common stock (subject to adjustment in certain circumstances), based upon the applicable market value of Elanco's common stock prior to settlement. The Reporting Person may elect to settle the purchase contracts prior to February 1, 2023 at the minimum settlement rate of 1.3021 shares of Elanco's common stock. Additionally the purchase contracts may be settled early by the Reporting Person or Elanco under certain circumstances described in the purchase contract.
  2. Represents the maximum number of shares of Elanco's common stock initially issuable upon settlement of the purchase contract included in the TEUs based on the maximum settlement rate.